X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.fiercepharma.com/pharma/tesaro-s-chemo-nausea-med-varubi-can-cause-anaphylaxis-company-warns
https://globenewswire.com/news-release/2017/10/25/1153687/0/en/TESARO-Announces-U-S-FDA-Approval-of-VARUBI-IV-for-Delayed-Nausea-and-Vomiting-Associated-With-Cancer-Chemotherapy.html
https://www.pharmacompass.com/pdf/news/tesaros-varuby-rolapitant-receives-approval-in-europe-1496315673.pdf
https://www.pharmacompass.com/pdf/news/tesaro-uk-varuby-rolapitant-receives-approval-in-europe-1496838419.pdf
http://www.pharmatimes.com/news/six_new_medicines_endorsed_for_eu_approval_1187675
http://www.pmlive.com/pharma_news/j_and_j_gets_chmp_backing_for_broader_darzalex_use_1187659
http://www.in-pharmatechnologist.com/Regulatory-Safety/Sanofi-Kevzara-to-be-resubmitted-to-FDA-after-fill-finish-plant-visit
http://www.fool.com/investing/2016/11/16/3-potential-acquisition-targets-for-gilead-science.aspx?
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm460838.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
http://www.fiercepharmaasia.com/story/tesaro-licenses-pdufa-status-candidate-rolapitant-chinas-jiangsu-hengrui/2015-08-03
Market Place
Share 
